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ABSTRACT
A Bayesian methodology has been developed for multiple quantitative trait loci (QTL) mapping of
complex binary traits that follow liability threshold models. Unlike most QTL mapping methods where
only one or a few markers are used at a time, the proposed method utilizes all markers across the genome
simultaneously. The outperformance of our Bayesian method over the traditional single-marker analysis
and interval mapping has been illustrated via simulations and real data analysis to identify candidate loci
associated with colorectal cancer.
TREMENDOUS advances have been achieved overthe last decade in the identification of genes un-
derlying many heritable traits with the greatest progress
limited almost entirely to those with Mendelian inher-
itance patterns and well-defined quantitative traits that
have relatively large and consistent effects. However,
many common pathologies afflicting the greatest num-
ber of individuals are not due to simple Mendelian
traits. Recent emphasis has been shifted to map com-
plex traits, which are caused by the sum of a complex
interaction between gene products and environmental
stimuli. Complicating the analysis of these types of traits
is the prediction that many are also controlled by genes
that have small effects individually, but whose cumula-
tive action is the cause of significant interindividual
variation. Due to the complex and often subtle nature
of phenotypic variation, traits with complex etiologies
have proven far more resistant to genetic analysis. Most
of the available quantitative trait loci (QTL) mapping
methods map only one or a few QTL at a time and
therefore are not efficient for mapping such complex
traits. Forward and stepwise selection procedures have
been proposed in searching for multiple QTL. Though
simple, these methods have their limitations, such as
the uncertainty of number of QTL, the sequential
model building that makes it unclear how to assess the
significance of the associated tests, etc.
To overcome this problem, Bayesian QTL mapping
(Satagopan et al. 1996; Sillanpaa and Arjas 1998;
Stephens and Fisch 1998; Yi and Xu 2000, 2001;
Hoeschele 2001) has been developed, in particular,
for detection of multiple QTL by treating the number of
QTL as a random variable and specifically modeling it
using reversible-jump Markov chain Monte Carlo (MCMC)
(Green 1995). Due to the change of dimensionality,
care must be taken in determining the acceptance prob-
ability for such a dimension change, which in practice
may not be handled correctly (Ven 2004). To avoid such
a problem by the uncertain dimensionality of parameter
space, Yi (2004) and Xu (2003) proposed a unified
Bayesian framework to identify multiple QTL using all
markers across the genome. The method of Xu (2003)
is based on a shrinkage idea to simultaneously evaluate
marker effects of the entire genome under the random
regression model by assigning each marker a normal
prior with mean 0 and an effect-specific variance. The
effect-specific prior variance was further assigned a
vague prior such that the variance was estimated from
the data. Those markers that have no effect on the trait
will be essentially shrunk down to 0. Similarly, Yi (2004)
adapted the stochastic search variable selection (SSVS)
approach of George and McCulloch (1993) to the
QTL mapping framework. SSVS is a variable selection
method that keeps all possible variables in the model
and limits the posterior distribution of nonsignificant
variables in a small neighborhood of 0 and therefore
eliminates the need to remove nonsignificant variables
from the model. In principle, Xu (2003) and Yi (2004)’s
methods are similar and both have the ability to control
the genetic variances of a large number of QTL where
each has small effect (Wang et al. 2005). Due to the
simplicity of Xu (2003), we decide to go with the unified
shrinkage method in this article.
Some quantitative traits do not have continuous mea-
surements, but rather are qualitative traits with, for ex-
ample, binary measurements. This research is mainly
motivated by a colorectal cancer susceptibility study. One
hundred thirty-five backcross mice of A/J 3 SPRET/EiJ F1
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(ASP F1) hybrids to A/J were given intraperitoneal in-
jections of the alkylating carcinogen azoxymethane
where 40% of the mice developed tumors. The goal
of the study was to identify susceptibility genes for colo-
rectal cancer. Mapping genes for such binary traits is
more complicated than that for continuous traits as cur-
rent QTL mapping methods are mainly limited to test
association between a marker and a binary trait with
simple chi-square tests. As an alternative, Hackett and
Weller (1995), Xu and Atchley (1996), and Visscher
et al. (1996) proposed interval mapping procedures for
complex binary disease traits assuming that the binary
traits are controlled by an underlying normally distrib-
uted liability. The quantitative liability is then modeled
by the usual quantitative genetics model. Due to the
apparent success of the unified Bayesian framework to
identify multiple QTL using all markers across the ge-
nome for normally distributed quantitative traits, the
systematic investigation of the unified Bayesian map-
ping for complex binary traits would be interesting and
useful. In this article, we propose the Bayesian method-
ology in mapping complex binary traits and investigate
its performance via extensive simulations. Detailed con-
vergence diagnostics are also presented.
STATISTICAL METHODS
The liability and threshold model: In the liability
model (Wright 1934a,b; Falconer 1965; Falconer
and Mackay 1996), a binary trait is assumed to be con-
trolled by a latent liability variable, which is normally
distributed. That is, suppose di and yi (i ¼ 1, . . . , n) are
the binary phenotype and the underlying liability, respec-
tively, of the ith individual; then the threshold model
assumes that there is a fixed threshold in the scale of
liability, t, which determines di. Specifically, di¼ 1, if yi . t;
otherwise di ¼ 0.
Marker analysis: Here we allow only QTL to be located
on markers. An extension to allow QTL to be located
between markers is discussed in the following section.
For backcross QTL data, we can describe the liability yi
by the following linear model,
yi ¼ m 1
XK
j¼1
xij aj 1 ei ; ð1Þ
where K is the total number of markers; m is the overall
population mean, xij is a dummy variable indicating the
genotype of the jth marker of individual i with xij¼ 1 or 0
if the marker genotype is homozygote or heterozygote,
respectively, aj is the partial regression coefficient, and ei
is the residual error with a distribution of N ð0;s2eÞ.
Note, aj describes the genetic effect of the jth marker
that partly absorbs the effects of all QTL located be-
tween markers j 1 and j 1 1, as shown by Zeng (1993).
Similarly, for an F2 population, the liability yi can be
related to QTL as






wij bj 1 ei ; ð2Þ









and wij ¼ 1 for aa with AA, Aa, and aa referring to the
three marker genotypes at each locus; aj and bj are the
additive and dominance effects of the jth marker; and m
and ei are defined the same as in the backcross model.
Since the latent liability y is unobserved, the mean m
and residual variance s2e can be set arbitrarily. For model
identifiability, we set t ¼ 0 and se ¼ 1 throughout the
presentation.
To employ the frequentist method via a likelihood
function requires calculation of the conditional proba-
bility, pi, of di¼ 1 given {xij, j¼ 1, 2, . . . , K}, which can be





(Xu and Atchley 1996), with ji ¼ m 1
PK
j¼1 xij aj for
the backcross, ji ¼ m 1
PK
j¼1 xij aj 1
PK
j¼1 wij bj for the












ð1 diÞlogð1 piÞ; ð4Þ
where pi is defined above. The maximum-likelihood
estimators (MLE) can be obtained by directly maximiz-
ing L. However, in practice, the number of markers is
often comparable to or even larger than the number of
observations. Under such circumstances, the maximum-
likelihood method will have very low efficiency or even
fail.
Below we describe the Bayesian method which over-
comes such a problem. We describe here only the basis
for the backcross population. With a minor modifica-
tion, it can be easily extended to an F2 design.
Bayesian modeling: In the Bayesian framework, both
the data and the parameters are treated as random, with
random variables being classified as observed and unob-
served. The goal of Bayesian analysis is to combine the
prior distribution of the unobserved variables with the
observed data to obtain a posterior distribution of the un-
known variables. The observed data in our QTL setup
are the binary responses S ¼ fdigni¼1, and the marker
genotypes X¼ {xij}, for i¼ 1, 2, . . . , n and j¼ 1, 2, . . . , K.
Our unobserved variables are the liability Y ¼ fyigni¼1,
the regression coefficients, B ¼ m; fajgKj¼1
 
, and the
variances associated with B;V ¼ fs2j g
K
j¼1.
By Bayes’ theorem, the joint posterior density of the
parameters {Y, B, V}, given the observed data {S, X}, is
pðY; B; V j S; XÞ
}pðS jY; B; V; XÞpðY jB; V; XÞpðB; V jXÞ: ð5Þ
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Inference is performed conditional on X and we suppress
this conditioning notation for the remainder of the article.








Specifically, we choose pðmÞ  1; pðaj js2j Þ ¼ fðaj ;s2j Þ,
and pðs2j Þ  1=s2j , where f(x, s2) is the density function
of normal distribution with mean zero and variance s2.
The first term in (5) is the conditional distribution of
the data given all the unknowns, which equals








fI ðyi . 0ÞI ðdi ¼ 1Þ1 I ðyi , 0ÞI ðdi ¼ 0Þg; ð7Þ
where I(A) is an indicator function, taking the value of 1
if condition A is true and 0 otherwise. Note that p(S j Y,
B, V) ¼ p(S j Y) because S depends solely on Y. The
second term in (5) is the conditional distribution of the
liability. Because the liability is normally distributed and
independent of each other given other variables, we have


















A MCMC method is used to generate the joint
posterior distribution of all unknowns given in (5).
Let c¼ {Y, B, V} be the collection of unknown variables.
For a given j, if the conditional distribution of cj given
the rest of variables has a known standard density, new cj
are drawn via Gibbs samples. Otherwise, we use the
Metropolis–Hastings algorithm to draw a new sample cj
according to a proposed density qðcj ; cj Þ. cj will be
accepted with probability min(1, r), where
r ¼
pðcj j t;cjÞqðcj ;cjÞ
pðcj j t;cjÞqðcj ;cj Þ
: ð9Þ
Here a negative subscript ( j ) denotes a vector with the
jth element removed.
We first initialize c as follows. The overall mean m and
the genetic effects of all QTL fajgKj¼1 are initialized with
zero while the variances fs2j g
K
j¼1 are initialized with 1.
Given the initial values of (B, V), we generate yi from the
corresponding truncated normal distributions,
pðyi jB; di ¼ 1Þ ¼
fðyi  ji ; 1Þ
FðjiÞ
I ðyi . 0Þ; ð10Þ
pðyi jB; di ¼ 0Þ ¼
fðyi  ji ; 1Þ
1FðjiÞ
I ðyi # 0Þ; ð11Þ
where F(x) is the standardized normal distribution
function. We describe below the steps for a single MCMC
iterative sweep t 1 1. Superscripts (t) signify the current
variables, and we begin with the initialized values for t¼ 0:
Step 1. Updating m: m(t11) is drawn from the poste-












Step 2. Updating aj for j ¼ 1, . . . , K: aðt11Þj is drawn from



































Step 3. Updating s2j for j ¼ 1, . . . , K: s
2ðt11Þ
j is sampled
from a scale-inverted x2-distribution, a2ðt11Þj =x
2
1,
where x21 is a x
2-distribution with 1 d.f.
Step 4. Updating yi for i¼ 1, . . . , n: yðt11Þi is drawn from a
truncated normal distribution (10) if di ¼ 1 or (11) if
di ¼ 0.
After this round of sampling, we have completed one
sweep of the MCMC and are ready to continue our
sampling for the next round by repeating steps 1–4 with
the new c. When the chain converges, the sampled pa-
rameters approximately follow the joint posterior dis-
tribution. From the joint posterior sample, one can
easily obtain the desired Bayesian estimates, such as the
posterior means and variances.
Simulations and real data analysis: The performance of
the proposed Bayesian method is evaluated by analyzing
a set of simulated backcross data.
A single chromosome with a length of 15 morgans is
simulated.Onthischromosome,301evenly spacedmarkers
(300 intervals, each 5 cM long) are located and two sets
of QTL are simulated. In the first setup, four QTL are
put along the genome with positions and effects listed in
Table 1. Here the QTL are only loosely linked and each
QTL explains 20% of the total liability variance. To
investigate the ability of the method to identify small
QTL effects and to separate closely linked QTL, 11 QTL
are evenly placed on the first half of the chromosome,
i.e., from 0 to 750 cM in the second setup. The QTL are













; 0:25; 0:25; 0:25; 0:25; 0:25.
The first QTL explains 43.54% of the total liability
variance and the second QTL explains half the size of
the first one and so on. The proportion of the total
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liability variance explained by the 11 QTL is H¼ 89.12%.
To demonstrate the advantages of the proposed method
over the traditional regression method, we simulate 300
individuals, which is smaller than the number of mark-
ers; traditional regression analysis fails if all markers are
included as covariates. Further, we have simulated 500
individuals to see how sample size affects QTL mapping.
For each simulated datum, the sampled parameter
values from the first 50,000 sweeps of the chain (burn-in
period) were discarded from the analysis. Then we per-
formed an additional 500,000 MCMC sweeps. After the
burn in, the final sample of observations was selected
every 50 sweeps to reduce serial correlation, resulting in
10,000 samples from the posterior.
Table 1 shows some summary statistics and Figure 1
shows the estimated QTL-effect profiles (the posterior
means of the marker effects) against marker positions
along the genome for normal data (Figure 1a) and
binary data (Figure 1b) from 10,000 sample states under
setup one with sample size 300.
Both profiles show clear signals of QTL at the simu-
lated positions. In most cases the estimated QTL effects
are close to the true values (Table 1). However, the anal-
ysis based on the binary data has reduced efficiency
relative to the analysis on the normal liability data di-
rectly. This is expected because of the reduced informa-
tion in binary data. The histograms of the posterior
distribution are also presented in Figure 2. The poste-
rior distributions are nearly normal shaped.
The results for setup two where some QTL are closely
linked (sample size ¼ 300) are presented in Figure 3.
For comparison, we also perform a simple chi-square test
at each marker. From Figure 3a, where log10(P-value)
of the single-marker analysis is plotted, we see many
markers that are significantly associated with the simu-
lated trait. Because the single-marker analysis fit only
one marker at a time, those markers that are correlated
with the simulated QTL will also be highly associated
with the trait. On the other hand, in the Bayesian
analysis result (Figure 3b), five large QTL are quite clear
and four of them are located at the simulated positions
with effects also close to the true values. To improve the
estimate power, we simulated 500 backcross individuals
on the basis of the same setup as above and applied both
single-marker and Bayesian analyses on them. The re-
sults are depicted in Figure 4. Clearly, the mapping
efficiency has been improved quite a lot when sample
size increases from 300 to 500 (Figure 4b), where six
clear QTL are given at the true positions with effects very
close to true values. The smallest QTL that the Bayesian
method can pick up in this example explains 2.72% of
the liability variance.
Real data analysis: Azoxymethane (AOM) is an alkylat-
ing carcinogen that causes strain-specific susceptibility
to the development of colorectal tumors in mice. Sus-
ceptible mice strains treated with AOM exhibit genetic
and pathologic changes similar to those in nonfamilial
or sporadic human colorectal cancer. We previously
characterized 32 inbred mouse strains for their sus-
ceptibility to AOM-induced colorectal tumors and iden-
tified the A/J strain as having one of the highest
sensitivities, with nearly 100% of mice developing co-
lorectal tumors (our unpublished results). In contrast,
the genetically distinct strain from the related Mus
spretus species, SPRET/EiJ, was found to be completely
resistant.
Figure 1.—Bayesian estimates of QTL effects in the simu-
lated backcross family under setup one. (a) Results from (un-
derlying) normal liability data and (b) results from binary
data. ‘‘x’’ refers to the simulated QTL position (x-axis) and ef-
fect (y-axis). The 95% confidence interval is bracketed by two
horizontal lines. The heights of the solid lines correspond to
the posterior means.
TABLE 1







effect SD P5 P95
1 0 1 1.05 0.14 0.82 1.29
(1.06) (0.06) (0.95) (1.16)
2 250 1 0.87 0.15 1.12 0.63
(0.98) (0.07) (1.10) (0.86)
3 500 1 1.00 0.15 0.76 1.25
(0.98) (0.07) (0.87) (1.09)
4 750 1 0.87 0.24 1.16 0.37
(0.97) (0.07) (1.09) (0.88)
SD, standard deviation of the estimated effect; P5 and P95,
the 5th and 95th percentiles of the posterior distribution, re-
spectively. Estimates obtained from normal data are given in
parentheses.
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For the current study, we set up a backcross of ASP F1
hybrids to A/J to generate backcross progeny. Two- to
3-month-old mice were given intraperitoneal injections
of AOM at 10 mg/kg of body weight once a week for
4 weeks. Subsequently, mice were killed by carbon dioxide
asphyxiation 20 weeks after the last AOM dose. A tail
clip, a liver sample, and the colon were dissected from
each mouse. Each colon was gently flushed with phos-
phate buffer saline solution and cut open along its
longitudinal axis. The position and size of tumors were
recorded before excising any colon tumors for histo-
logical verification. Tails, livers, and colons were then
placed into labeled Eppendorf tubes and stored at80.
DNA was isolated from liver or tail samples from each
mouse by phenol-chloroform extraction. One hundred
thirty-five backcross mice were genotyped using the
Illumina SNP genotyping platform. Two hundred fifty-
four informative markers were used that distinguished
the A/J strain from the SPRET/EiJ strain. ASP F1 mice
were found to be nearly tumor free with 5% of mice
developing a single colorectal tumor. Analysis of the
135 mice in the backcross population revealed that 40%
of mice developed AOM-induced colorectal tumors
(Figure 5).
Since 5% of ASP F1 mice still developed a single
colorectal tumor, we recategorized the backcross ani-
mals into two groups, with one group being tumor free
or having a single tumor while the second group was
backcross mice developing more than one tumor. The
analysis was based on this recategorized binary trait and
is summarized in Figure 6. Due to the small sample size,
no significant results were identified. However, one re-
gion on chromosome 6 is promising. This region encom-
passes a previously detected susceptibility locus for
AOM-induced colorectal tumors (Ruivenkamp et al.
2003). We are currently working on collecting another
140 backcross mice to confirm the findings on chromo-
some 6. For comparison, the analysis based on a single chi-
square test was also performed. Again, the smallest P-value
is on chromosome 6, which is consistent with the Bayesian
analysis, but it does not survive the genomewide 5%
significance level either. Another interesting region
indicated by our analysis is located on chromosome
11, which deserves further investigation as well.
Figure 2.—Histograms for the posterior QTL effects at the four simulated markers for binary data (left) and normal data
(right).
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Interval mapping: In this section, we extend the QTL
mapping on markers to a more general situation where
QTL are allowed to be located at any position within
marker intervals.
Bayesian modeling: Wang et al. (2005) developed a
method for normal phenotypes that allows a QTL to
take a position varying within a marker interval rather
than fixed at a marker. They assumed that each marker
interval is associated with a QTL, and thus the number
of putative QTL is identical to the number of intervals.
In their model, the conditional distribution of the QTL
genotype given the marker genotypes is derived from a
Markov model under the assumption of no segregation
inference. The main difference between interval map-
ping and marker analysis is that for interval mapping,
the QTL positions and QTL genotypes are unobserved,
while for marker analysis, the QTL positions are fixed at
markers and also QTL genotypes are observed. A major
advantage of the Bayesian analysis is that the unobserved
QTL positions and QTL genotypes can be treated as ran-
dom variables and sampled via the MCMC procedure.
Therefore, for interval mapping, we need only to add ad-
ditional steps to the MCMC procedure described above
for sampling the QTL positions and QTL genotypes.
For interval mapping, the observed variables are the
same as those of the marker analysis, which include S
and the marker genotypes M¼ {mij} (i¼ 1, 2, . . . , n; j¼ 1,
2, . . . , K). (Here we change the notation for the marker
genotypes from X to M since we reserve X for QTL
genotypes. In the marker analysis, the QTL are markers
themselves and therefore we refer to marker genotypes
as X.) For unobserved variables, besides those in the
marker analysis {Y; B; V}, there are additional variables,
which include the QTL positions, l¼ {lj} for j¼ 1, 2, . . . ,
p; and the QTL genotypes X¼ {xij} for i¼ 1, 2, . . . , n and
j ¼ 1, 2, . . . , p, where p is the total number of intervals,
which in general #K  1, and the equality holds only if
one chromosome is considered in the analysis.
Now the joint posterior density of the parameters {Y,
l, X, B, V}, given the observed data {S, M}, is
pðY;B;V;l;X j S;MÞ
} pðS jY;B;V;l;X;MÞpðY jB;V;l;X;MÞpðB;V;l;X jMÞ: ð14Þ
Again, inference is performed conditional on M and we
suppress this conditioning notation for the remainder
of the article.



















The prior distributions for m, aj, and s
2
j are the same as
in the marker analysis while for the QTL positions and
genotypes, we choose the following prior distributions,
p(lj)¼ 1/dj and xij ¼ 1 or 1 with probability 12 each for
i¼ 1, 2, . . . , n, j¼ 1, 2, . . . , p, where dj is the length of the
jth marker interval.
To sample unobserved variables, first we sample Y, B,
V the same way as described in steps 1–4 for the marker
analysis except that all xij, which are known in the marker
analysis, should be replaced by xðtÞij , samples from the t th
iteration. Then the following extra steps are needed to
sample l, X:
Step 5. Update QTL genotypes: The QTL genotype
xðt11Þij (i ¼ 1, 2, . . . , n; j ¼ 1, 2, . . . , p) is updated one
Figure 3.—Estimates of QTL effects in the sim-
ulated backcross family (n ¼ 300) with 11 QTL of
different genetic effects. (a) Single-marker analy-
sis based on a chi-square test; (b) Bayesian anal-
ysis. ‘‘x’’ refers the simulated QTL position (x-
axis) and effect (y-axis). The 95% confidence in-
terval is bracketed by two horizontal lines. The
heights of the solid lines in b correspond to
the posterior means.
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individual and one locus at a time, on the basis of
their flanking marker information. Specifically, xðt11Þij
is sampled from the conditional probability distribu-
tion p(x), which equals




i R ; l
ðtÞ
j ÞP
h2f1;11g pðyi j x ¼ h;Bðt11Þ;X
ðtÞ








where m jiL and m
j
iR
are the two flanking markers of the








conditional probability of the QTL (at lðtÞj ) given
the two flanking markers; XðtÞiðjÞ ¼ x
ðt11Þ




xðtÞið j11Þ; . . . ; x
ðtÞ






















Step 6. Update QTL positions: lðt11Þj is sampled via a
Metropolis–Hastings approach since there is no closed
form for the conditional posterior probability density
of a QTL position. We first sample a new position lj





j 1 d with d being a tuning parameter, which we
take a value of 2 cM in subsequent simulations. lj will
then be accepted or rejected according to the prob-
ability min(1, a), where
Figure 5.—Number of tumors in two parental
strains A/J and SPRET/EiJ, plus ASP F1 and back-
cross strains.
Figure 4.—Estimates of QTL effects in the sim-
ulated backcross family (n ¼ 500) with 11 QTL of
different genetic effects. (a) Single-marker analy-
sis based on chi-square test; (b) Bayesian analysis.
‘‘x’’ refers the simulated QTL position (x-axis)
and effect (y-axis). The 95% confidence interval
is bracketed by two horizontal lines. The heights
of the solid lines in b correspond to the posterior
means.


























  : ð17Þ
If neither lðtÞj nor l

j is within d-distance away from the
ends of the interval, qðlj Þ ¼ qðl
ðtÞ
j Þ ¼ 1=ð2dÞ. How-
ever, if lðtÞj or/and l

j are within d-distance from one
end of the interval, then
qðlj Þ ¼
1
d 1 minðd; tj Þ
; or=and qðlðtÞj Þ ¼
1
d 1 minðd; tðtÞj Þ
; ð18Þ
where tðtÞj is the distance of l
ðtÞ
j from the nearest end
of the interval; similarly, tj is the distance of l

j from
the nearest end of the interval.
After these two extra steps for sampling l, X, one
MCMC iteration is done and we then continue our sam-
pling for the next round by repeating steps 1–6 with the
new c.
TABLE 2
QTL parameters and their positions





















Figure 7.—Bayesian estimates of QTL effects in the simu-
lated backcross family with four QTL for continuous and bi-
nary data. ‘‘x’’ refers the simulated QTL position (x-axis) and
effect (y-axis). The 95% confidence interval is bracketed by
two horizontal lines. The heights of the solid lines correspond
to the posterior means.
Figure 6.—(a) Bayesian analysis; (b)
single-marker analysis based on a chi-
square test. Vertical dotted lines are
used to separate the chromosomes.
The 95% confidence intervals are brack-
eted by x’s and shown at the two posi-
tions with the highest posterior means.
The heights of the solid lines in a corre-
spond to the posterior means.
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Simulation studies: For interval mapping, a backcross
population of 500 individuals was simulated. We in-
vestigated a single large chromosome of 24 M that was
covered by 121 evenly spaced markers (120 intervals,
each 20 cM long). Two sets of QTL are simulated. In the
first setup, four QTL are placed at 50, 450, 850, and 1250
cM with effects 1, 1, 1, and 1, respectively. The sec-
ond simulation setups are described in Table 2. Figure 7
shows the estimated QTL effect against QTL positions
along the genome for continuous and binary data for
setup one. The QTL signals are clearly shown at the
simulated positions for both cases. The QTL effects are
almost equal to the true values in the normal case but a
little larger than the true values in the binary case.
Figure 8 presents the QTL positions and effects along
with the real positions and effects for continuous and
binary data, respectively, for setup two. It is shown that
the Bayesian shrinkage method performs better for
normal data than for binary data, especially for those
QTL that locate in the region beyond 100 cM and have
small effects. Parameters of closely linked QTL are hard
to estimate. For example, the following QTL pairs, (5,
6), (10, 11), and (16, 17), are so tightly linked that they
are inseparable in both normal and binary data cases.
QTL 7 and 8, which are closely linked and have the same
size but with opposite directions, are not detected in
either data set. Nevertheless, for binary data, our method
can clearly localize separable QTL and QTL with large
effects. A much denser marker set along with a larger
population size is required to resolve QTL with tight
linkage and small effect.
Convergence diagnostics tests: Two convergence diag-
nostics tests are performed using convergence diagnosis
and output analysis (CODA) software (Best et al. 1995) to
make sure that the sample is representative of the under-
lying stationary distribution. The parameters we consider
here include m and the effect of four markers at which
the true QTL are located. Figure 9 shows the autocorre-
lation function against the lag for the setup one simu-
lation described in the Marker analysis section, where the
number of markers is larger than the number of samples.
The autocorrelation appears to be very small after lag 20
for all five parameters. The small autocorrelation shows
no indication of slow convergence for the chain. For the
same data set, we run five parallel Markov chains with the
same length 10,000 using very different initial values to
test Gelman and Rubin statistics. Figure 10 shows plots
for the 50 and 97.5% quantiles of the sampling distribu-
tion for the shrink factor for above five parameters. The
plots in Figure 10 show that both the median and the
97.5% quantiles stabilize around the expected value 1.0,
indicating that the Markov chains converge to their
limiting distribution.
DISCUSSION
The Bayesian method developed in Xu (2003) has
been extended to complex binary traits assuming the
Figure 8.—Bayesian estimates of
QTL effects in the simulated backcross
family x with 20 QTL for continuous
and binary data. The heights of the solid
lines correspond to the posterior means.
‘‘x’’ refers to the simulated QTL position
(x-axis) and effect (y-axis).
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threshold model. The results outperform the single-
marker chi-square test. The major advantage of using
the threshold model is that once the underlying liability
is generated, all other unknowns have conditional
posterior distributions identical to those already given
in the Bayesian analysis of normal data. This methodol-
ogy can be easily generalized to multiple-ordered cate-
gorical traits. As an alternative to the approach of the
liability augmentation, one can directly use the relation-
ship (3) between the binary phenotype and the model
effects. The problem is that normal is not a conjugate
prior to logistic distribution and therefore Gibbs sam-
pling will not work in this case. The Metropolis–Hastings
algorithm or some complicated sampling scheme like
ARMS (Gilks and Wild 1992) can be used but it is less
efficient than the Gibbs sampling. The method has been
implemented in C and the source codes are available
from http://www.bios.unc.edu/hhuang/QTLBinary.
The most striking feature of the Bayesian analysis is
that the estimated profiles show clear signal only at a few
positions with all remaining markers having effects that
are close to zero. This shrinkage effect has been ex-
plained in detail in Xu (2003). The key point is that
the priors of the variances of QTL effects are allowed
to vary across markers instead of being fixed. This is
demonstrated clearly in the special forms of (12) and
(13). A large aj will have large variance sj and thus a
negligible 1=s2j , which will lead to a small shrinkage
effect. However, if a QTL has a small effect, a small s2j





ij ; thus aj will be very likely shrunk
toward zero.
In this article, we have considered the cases that QTL
are fixed at the observed markers and that one QTL can
be located within each marker interval. For densely
distributed markers, the former method is a good ap-
proximation to the latter one since the two methods
make almost no difference. However, the first method
may lead to biased results when the marker density is not
high enough. One assumption made in the second
method is that each interval contains at most one QTL,
which may not be true if two markers are far apart. Yi
(2004) has developed a new method that assumes that,
on average, there is at most one QTL in every d cM. The
pseudomarkers are introduced to make every interval
the same length. The genotypes at pseudomarkers are
Figure 9.—Autocorrelation function for
the study of setup one. Here b0 represents
m and b1–b4 represent the effects of four
markers at which the true QTL are located.
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treated as missing and can be easily handled in a Bayes-
ian framework.
Several frequency-based model selection methods
have been developed for mapping multiple QTL. To re-
duce modeling space, Carlborg and Andersson (2002)
included only those markers that are significantly asso-
ciated with the trait from the single-locus model in
the multiple-marker model. Coffman et al. (2005) first
selected one marker per linkage group, regardless of
whether that marker is significantly associated with the
trait or not, and then fitted their model on the basis of
the chosen markers. Both approaches may identify
multiple linked QTL in a biased way as mentioned in
Kao et al. (1999). Our method keeps all possible models
under consideration and therefore avoids potential se-
lection bias of the above approaches. Although the vari-
able dimension of our model is very high, our Bayesian
model is simple and straightforward since standard
Gibbs are mainly used in each MCMC iteration. We
have tested the method on 300 individuals with 2000
markers and it took less than only 1 hr to generate
100,000 sweeps on a 3-GH linux machine. Convergence
diagnostic tests also show that our method converges
quickly and well.
Our method is particularly designed for the situation
where no any prior information for the number of QTL
and their positions is available. However, it should be
noted that the method can be modified to include such
prior information. For example, instead of using a
noninformative prior for s2j , we may use different priors
for s2j on the basis of the available information from
other studies. For example, if there is strong evidence of
a QTL in a region, we may let s2’s in the region follow a
uniform prior on ½a, b with a being large. On the other
hand, if there is strong evidence that no such QTL exists
in another region, we may then let s2’s in this region
follow a uniform prior on ½0, c with c being small. Of
course, introducing such region-specific priors compli-
cates the MCMC procedure but would be beneficial
especially when the sample size is small.
Further, our model currently can handle only main
QTL effects. Another important extension is to include
epistatic effects in the model. Several articles (Yi and Xu
2002; Narita and Sasaki 2004) have discussed this issue
Figure 10.—Plot of Gelman and Rubin’s
shrink factor for the study of setup one. Here
b0 represents m and b1–b4 represent the ef-
fects of four markers at which the true QTL
are located.
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for normal traits. To include epistatic effects, an upper
bound of the number of QTL in the model (Yi et al.
2005) has to be placed, which is extremely useful and
necessary since the number of variables dramatically
increases when epistatic effects are considered.
Finally, it worth mention that we have run marker
analysis only on the real data. We have found that a
significantly amount of markers are in segregation dis-
tortion, which will affect the genetic map that the in-
terval mapping heavily relies on. However, marker
analysis is unrelated to the genetic map and therefore
is more robust to such segregation distortion. We are
currently carefully investigating the causes of such seg-
regation distortion, which itself may provide us insights
on the etiology of colorectal cancer.
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